Latest filing published 20 Aug 2021 for Propanc Biopharma, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Julian Norman Kenyon: trading record in brief
This profile gathers the share dealings of Julian Norman Kenyon in Propanc Biopharma, Inc., where the filings describe the role as senior executive. Between 4 February 2015 and 17 August 2021, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 20 August 2021: a share grant, in Propanc Biopharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julian Norman Kenyon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,420,000 shares0Common stock, par value $0.001SEC:0001493152-21-020759:0
1 of 1 declaration